Bioactive Compounds and Therapeutic Applications of Sanguisorba officinalis

Sanguisorba officinalis has long been recognised for its rich complement of bioactive molecules, notably phenolic acids (such as gallic, ellagic and vanillic acids), condensed tannins, flavonoids, terpene glycosides (ziyuglycosides) and saponins. These constituents underpin a spectrum of therapeutic activities. In cardiovascular models, extracts exert vasorelaxant and antihypertensive effects via endothelium-dependent nitric oxide/cGMP signalling, modulation of voltage-gated K+ channels and inhibition of extracellular Ca2+ influx. In oncology, key monomers potentiate chemotherapeutic agents by promoting reactive oxygen species-mediated, mitochondria-caspase-dependent apoptosis, while also engaging autophagic pathways. Antioxidant and antibacterial potential has been demonstrated in extracts applied topically, with selected phenolic acids permeating and accumulating in skin tissues, supporting dermato-cosmetic development. Additional studies reveal enzyme-inhibitory actions relevant to metabolic disorders and antiproliferative effects against diverse tumour cell lines. Traditional applications in haemostasis and myelosuppression find mechanistic support in the activation of focal adhesion kinase and Erk1/2, and in modulation of marrow cytokines. Together, these findings highlight the global significance of S. officinalis in nutraceutical, pharmaceutical and cosmeceutical innovation.

Research from Nature Portfolio

A seminal investigation demonstrated that water extracts of the root substantially enhance the cytotoxicity of fluoropyrimidine therapy in colorectal carcinoma cells. Co-treatment elevated intracellular reactive oxygen species, altered the Bax/Bcl-2 ratio, induced mitochondrial dysfunction and triggered caspase-9/3 activation, culminating in apoptosis. Gallic, catechinic and ellagic acids were identified as principal synergistic constituents. This work provides a mechanistic foundation for integration of S. officinalis monomers into adjuvant cancer treatments.

Bioactive Compounds and Therapeutic Applications of Sanguisorba officinalis publication trend

The graph below shows the total number of articles in bioactive compounds and therapeutic applications of sanguisorba officinalis across all publications each year (not limited to Nature Index journals).

Technical terms

Saponins: Glycosidic compounds comprising a sugar moiety linked to a triterpenoid or steroid aglycone, noted for membrane-perturbing and immunomodulatory effects.

Tannins: Polyphenolic molecules capable of protein binding, conferring antioxidant, antimicrobial and haemostatic properties.

Phenolic acids: Aromatic acids with one or more hydroxyl groups, contributing to free-radical scavenging, enzyme inhibition and antimicrobial action.

Reactive oxygen species (ROS): Chemically reactive molecules derived from oxygen capable of signalling or inducing oxidative stress and apoptosis.

Caspase-dependent apoptosis: Programmed cell death executed by a cascade of cysteine proteases (caspases) that orchestrate cellular dismantling.

NO/cGMP pathway: Vasodilatory signalling cascade in which endothelial nitric oxide stimulates guanylate cyclase to produce cyclic GMP, leading to smooth-muscle relaxation.

Vasorelaxation: The relaxation of vascular smooth muscle resulting in vessel dilation and reduced vascular resistance.

References

1. Hypotensive and Vasorelaxant Effects of Sanguisorbae Radix Ethanol Extract in Spontaneously Hypertensive and Sprague Dawley Rats. Nutrients (2023).
2. Sanguisorba officinalis L. ethanolic extracts and essential oil – chemical composition, antioxidant potential, antibacterial activity, and ex vivo skin permeation study. Frontiers in Pharmacology (2024).
3. Sanguisorba officinalis L synergistically enhanced 5-fluorouracil cytotoxicity in colorectal cancer cells by promoting a reactive oxygen species-mediated, mitochondria-caspase-dependent apoptotic pathway. Scientific Reports (2016).
4. A Comprehensive Review of Genus Sanguisorba: Traditional Uses, Chemical Constituents and Medical Applications. Frontiers in Pharmacology (2021).
5. Terpene Glycosides from the Roots of Sanguisorba officinalis L. and Their Hemostatic Activities. Molecules (2012).
6. Saponins from Sanguisorba officinalis Improve Hematopoiesis by Promoting Survival through FAK and Erk1/2 Activation and Modulating Cytokine Production in Bone Marrow. Frontiers in Pharmacology (2017).
7. Isolation and Identification of the Phenolic Compounds from the Roots of Sanguisorba officinalis L. and Their Antioxidant Activities. Molecules (2012).
8. Profile and Content of Phenolic Compounds in Leaves, Flowers, Roots, and Stalks of Sanguisorba officinalis L. Determined with the LC-DAD-ESI-QTOF-MS/MS Analysis and Their In Vitro Antioxidant, Antidiabetic, Antiproliferative Potency. Pharmaceuticals (2020).